Decreased Zinc and Increased Copper in Individuals with Anxiety

Overview

Journal Nutr Metab Insights

Publisher Sage Publications

Specialty Endocrinology

Date 2013 Aug 16

PMID 23946656

Citations 22

Authors

A J Russo

Affiliations

Soon will be listed here.

Abstract

Aim: To assess plasma zinc and copper levels in individuals with anxiety and to test the hypothesis that there is a relationship between copper and zinc concentration and improved symptoms.

Subjects And Methods: Serum from 38 individuals with anxiety and 16 neurotypical age, gender and size similar controls were tested for plasma zinc and copper concentration using inductively-coupled plasma-mass spectrometry. Zinc and copper levels, pre and post therapy, were compared and assessed for perceived anxiety symptoms.

Results: In this preliminary study, individuals with anxiety had significantly higher plasma levels of Cu (P = 0.0348), Cu/Zn (P = 0.0493) and lower Zn (P = 0.0294) compared to controls. Zn levels normalized (increased to the normal range) and Cu/Zn significantly decreased after zinc therapy (P = 0.0004, P = 0.0033, respectively), but Cu did not significantly decrease (0.3577). These same patients improved significantly with respect to perceived overall symptoms after zinc and anti-oxidant therapy (P = 0.013).

Discussion: These results suggest an association between Zn plasma levels and individuals with anxiety, demonstrate that zinc therapy is effective in increasing zinc plasma levels, and show that zinc supplementation may play a role in improved symptoms.

Citing Articles

Antioxidants in neuropsychiatric disorder prevention: neuroprotection, synaptic regulation, microglia modulation, and neurotrophic effects.

Liu F, Bai Q, Tang W, Zhang S, Guo Y, Pan S Front Neurosci. 2024; 18:1505153.

PMID: 39703344 PMC: 11655488. DOI: 10.3389/fnins.2024.1505153.

Novel hypothesis and therapeutic interventions for irritable bowel syndrome: interplay between metal dyshomeostasis, gastrointestinal dysfunction, and neuropsychiatric symptoms.

Nakagawa Y, Yamada S Mol Cell Biochem. 2024; .

PMID: 39503802 DOI: 10.1007/s11010-024-05153-3.

Biomarkers in the Diagnosis and Prediction of Medication Response in Depression and the Role of Nutraceuticals.

Beer C, Rae F, Semmler A, Voisey J Int J Mol Sci. 2024; 25(14).

PMID: 39063234 PMC: 11277518. DOI: 10.3390/ijms25147992.

Loss of Slc39a12 in hippocampal neurons is responsible for anxiety-like behavior caused by temporomandibular joint osteoarthritis.

Shen Z, Fan C, Ding C, Xu M, Wu X, Wang Y Heliyon. 2024; 10(4):e26271.

PMID: 38375280 PMC: 10875581. DOI: 10.1016/j.heliyon.2024.e26271.

Advances in the Treatment of Autism Spectrum Disorder: Current and Promising Strategies.

Yenkoyan K, Ounanian Z, Mirumyan M, Hayrapetyan L, Zakaryan N, Sahakyan R Curr Med Chem. 2023; 31(12):1485-1511.

PMID: 37888815 PMC: 11092563. DOI: 10.2174/0109298673252910230920151332.

References

McNall A, Etherton T, Fosmire G . The impaired growth induced by zinc deficiency in rats is associated with decreased expression of the hepatic insulin-like growth factor I and growth hormone receptor genes. J Nutr. 1995; 125(4):874-9. DOI: 10.1093/jn/125.4.874. View

Aggett P . Acrodermatitis enteropathica. J Inherit Metab Dis. 1983; 6 Suppl 1:39-43. DOI: 10.1007/BF01811322. View

Maes M, De Vos N, Demedts P, Wauters A, Neels H . Lower serum zinc in major depression in relation to changes in serum acute phase proteins. J Affect Disord. 2000; 56(2-3):189-94. DOI: 10.1016/s0165-0327(99)00011-7. View

Russo A . Decreased Serum Hepatocyte Growth Factor (HGF) in Individuals with Depression Correlates with Severity of Disease. Biomark Insights. 2010; 5:63-7. PMC: 2918354. DOI: 10.4137/bmi.s5183. View

Alonso J, Angermeyer M, Bernert S, Bruffaerts R, Brugha T, Bryson H . Prevalence of mental disorders in Europe: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project. Acta Psychiatr Scand Suppl. 2004; (420):21-7. DOI: 10.1111/j.1600-0047.2004.00327.x. View

Brown R, Sander C, Argos P . The primary structure of transcription factor TFIIIA has 12 consecutive repeats. FEBS Lett. 1985; 186(2):271-4. DOI: 10.1016/0014-5793(85)80723-7. View

Russo A . Decreased Serum Hepatocyte Growth Factor (HGF) in Individuals with Anxiety Increases After Zinc Therapy. Nutr Metab Insights. 2013; 3:43-8. PMC: 3736887. DOI: 10.4137/NMI.S5495. View

Alonso J, Lepine J . Overview of key data from the European Study of the Epidemiology of Mental Disorders (ESEMeD). J Clin Psychiatry. 2007; 68 Suppl 2:3-9. View

Issakidis C, Andrews G . Service utilisation for anxiety in an Australian community sample. Soc Psychiatry Psychiatr Epidemiol. 2002; 37(4):153-63. DOI: 10.1007/s001270200009. View

10.

Prasad A . Role of zinc in human health. Bol Asoc Med P R. 1991; 83(12):558-60. View

11.

Bouayed J, Rammal H, Dicko A, Younos C, Soulimani R . Chlorogenic acid, a polyphenol from Prunus domestica (Mirabelle), with coupled anxiolytic and antioxidant effects. J Neurol Sci. 2007; 262(1-2):77-84. DOI: 10.1016/j.jns.2007.06.028. View

12.

Xie X, Smart T . Properties of GABA-mediated synaptic potentials induced by zinc in adult rat hippocampal pyramidal neurones. J Physiol. 1993; 460:503-23. PMC: 1175226. DOI: 10.1113/jphysiol.1993.sp019484. View

13.

Zalewski P, FORBES I, Betts W . Correlation of apoptosis with change in intracellular labile Zn(II) using zinquin [(2-methyl-8-p-toluenesulphonamido-6-quinolyloxy)acetic acid], a new specific fluorescent probe for Zn(II). Biochem J. 1993; 296 ( Pt 2):403-8. PMC: 1137710. DOI: 10.1042/bj2960403. View

14.

Tuthill A, Slawik H, ORahilly S, Finer N . Psychiatric co-morbidities in patients attending specialist obesity services in the UK. QJM. 2006; 99(5):317-25. DOI: 10.1093/qjmed/hcl041. View

15.

Nowak G, Zieba A, Dudek D, Schlegel-Zawadzka M, Pilc A . [Zinc homeostasis and glutamatergic system in the pathogenesis and treatment of depression]. Psychiatr Pol. 2001; 35(2):257-66. View

16.

Halsted J, Ronaghy H, Abadi P, Haghshenass M, Amirhakemi G, Barakat R . Zinc deficiency in man. The Shiraz experiment. Am J Med. 1972; 53(3):277-84. DOI: 10.1016/0002-9343(72)90169-6. View

17.

McNulty T, Taylor C . Extracellular heavy-metal ions stimulate Ca2+ mobilization in hepatocytes. Biochem J. 1999; 339 ( Pt 3):555-61. PMC: 1220190. View

18.

Ben-Ari Y, Cherubini E . Zinc and GABA in developing brain. Nature. 1991; 353(6341):220. DOI: 10.1038/353220a0. View

19.

MILLER W, BLACKMON D, GENTRY R, PITTS W, Powell G . Absorption, excretion, and retention of orally administered zinc-65 in various tissues of zinc-deficient and normal goats and calves. J Nutr. 1967; 92(1):71-8. DOI: 10.1093/jn/92.1.71. View

20.

Tom Dieck H, Doring F, Roth H, Daniel H . Changes in rat hepatic gene expression in response to zinc deficiency as assessed by DNA arrays. J Nutr. 2003; 133(4):1004-10. DOI: 10.1093/jn/133.4.1004. View